Graphical Abstract Highlights d Mitochondrial transhydrogenase (Nnt) normally regenerates NADPH from NADH d Pathologic workload reverses Nnt to deplete NADPH and antioxidative capacity d Reverse Nnt induces mitochondrial oxidative stress and necrosis d Defective Nnt in C57BL/6J mice ameliorates pressure overload-induced heart failure SUMMARY Mitochondrial reactive oxygen species (ROS) play a central role in most aging-related diseases. ROS are produced at the respiratory chain that demands NADH for electron transport and are eliminated by enzymes that require NADPH. The nicotinamide nucleotide transhydrogenase (Nnt) is considered a key antioxidative enzyme based on its ability to regenerate NADPH from NADH. Here, we show that pathological metabolic demand reverses the direction of the Nnt, consuming NADPH to support NADH and ATP production, but at the cost of NADPH-linked antioxidative capacity. In heart, reverse-mode Nnt is the dominant source for ROS during pressure overload. Due to a mutation of the Nnt gene, the inbred mouse strain C57BL/6J is protected from oxidative stress, heart failure, and death, making its use in cardiovascular research problematic. Targeting Nntmediated ROS with the tetrapeptide SS-31 rescued mortality in pressure overload-induced heart failure and could therefore have therapeutic potential in patients with this syndrome.
In Brief
The mitochondrial transhydrogenase (Nnt) normally regenerates NADPH from NADH to bolster antioxidative capacity. Nickel et al. show that pathological workload reverses the Nnt reaction and depletes NADPH in the mouse heart, which increases ROS production and leads to maladaptive cardiac remodeling in heart failure.
INTRODUCTION
While mitochondria are the major source of cellular ATP, they can also emerge as important generators of reactive oxygen species (ROS) (Balaban et al., 2005; Murphy, 2009 ). Increased mitochondrial ROS production plays an important role in aging (Schriner et al., 2005 ) and many aging-related diseases, including neurodegenerative (Lin and Beal, 2006) , metabolic (Lee et al., 2010) , and cardiac diseases (Dai et al., 2009) . Chronic heart failure is the most frequent cause of hospitalization in persons aged R65 years and commonly results from myocardial infarction and/or hypertension (Roger, 2013) , and in both scenarios, mitochondrial ROS contribute to deterioration of cardiac function (Dai et al., 2012; Matsushima et al., 2006) . In heart, ROS impair excitation-contraction coupling, cause arrhythmias (Wagner et al., 2013) , activate prohypertrophic signaling (Ago et al., 2008) , and induce apoptotic and/or necrotic cell death through activation of the permeability transition pore (PTP) (Halestrap, 2005) . Recent advances in pharmacology targeting mitochondrial ROS production provide novel therapeutic options in a broad spectrum of diseases (Smith et al., 2012; Szeto, 2014) and require a precise understanding of the regulation of mitochondrial ROS production in physiology and disease.
The heart is an organ with uniquely high demands of ATP. During exercise, ATP production can increase $4-fold, requiring efficient adaptation of respiration through ADP and Ca 2+ (Balaban, 2002; Cortassa et al., 2006) . A physiological increase in workload is triggered by b-adrenergic stimulation, which increases ADP (through ATP hydrolysis) and at the same time, cytosolic Ca 2+ ( Figure 1A ). While ADP accelerates respiration and oxidizes NADH to NAD + by stimulating ATP production at the F 1 F o -ATP synthase, Ca 2+ enters mitochondria and activates Krebs cycle dehydrogenases to regenerate NADH. This ''parallel activation'' of respiration maintains constant ratios of ATP/ADP and NADH/NAD + over a wide range of physiological workloads (Balaban, 2002) .
We discovered recently that mitochondrial Ca 2+ uptake is also important to maintain NADPH for the elimination of hydrogen peroxide (H 2 O 2 ), since all enzymes that regenerate mitochondrial NADPH derive their substrates from the Krebs cycle (Kohlhaas et al., 2010) (Figure 1A) . In heart failure, disturbed Ca 2+ and Na + handling hamper mitochondrial Ca 2+ uptake and thus, provoke NADH and NADPH oxidation and mitochondrial ROS emission (Kohlhaas et al., 2010) . These and other studies led to the concept of ''redox-optimized ROS balance'' (Aon et al., 2010) , which implies that both production of superoxide ( d O 2 À ) at the electron transport chain (ETC; fueled by NADH) and elimination of H 2 O 2 (by NADPH-dependent enzymes) are favored by reduced redox states ( Figure 1A ). In this scenario, mitochondria are optimized to maximize energy output while keeping H 2 O 2 overflow to a minimum by operating in an intermediate redox state, while extreme oxidation or reduction can induce oxidative stress (Aon et al., 2010) .
The nicotinamide nucleotide transhydrogenase (Nnt) is at the critical interface between the NADH and NADPH pools in mitochondria, and despite a high abundance in the heart, its precise role for the regulation of mitochondrial ROS production and elimination is not well understood. The Nnt catalyzes the reaction NADH + NADP + 4 NADPH + NAD + and is coupled to the protonmotive force (Dm H ; Figure 1A ). Since high Dm H in energized mitochondria favors NADPH production, the Nnt is deemed to be a key antioxidative enzyme (Rydströ m, 2006) . Recently, it was discovered that C57BL/6 mice from The Jackson Laboratories (BL/6J) have a loss-of-function mutation in the gene encoding the Nnt by the missense of exons 7-11, accounting for glucose intolerance of this strain (Toye et al., 2005) . In pancreatic islet cells exposed to high glucose, deletion of the Nnt led to oxidative stress and impaired ATP production and insulin release (Freeman et al., 2006; Toye et al., 2005) . Furthermore, BL/6J mice are more sensitive to deletion of Mn 2+ -dependent superoxide dismutase (Mn-SOD) than other strains by developing cardiomyopathy, which was also related to the Nnt mutation (Huang et al., 2006) and ameliorated by re-expressing one wild-type Nnt allele in BL/6J mice (Kim et al., 2010) .
Here, we report that opposite to this prevailing view of the Nnt as an antioxidative enzyme, it switches to a pro-oxidative mode in situations of pathologic cardiac workload by reversing its direction, oxidizing NADPH to regenerate NADH for ATP production, but at the cost of the NADPH-dependent antioxidative capacity. This reverse-mode Nnt reaction increases mitochondrial ROS emission and accounts for maladaptive cardiac remodeling and mortality in response to pressure overload, while BL/6J mice lacking a functional Nnt are protected from heart failure. Since BL/6J is the most commonly used mouse strain in biomedical research, these data indicate that in numerous studies that applied cardiac pressure overload in this strain, oxidative stress was systematically underestimated. Our results further emphasize the importance of mitochondrial ROS production for the progression of heart failure and the feasibility of targeting mitochondria to protect the heart from remodeling and contractile dysfunction.
RESULTS

Expression and Activity of Nnt and Other NADPH-Regenerating Enzymes
In agreement with previous studies, exons 7-11 of the gene encoding Nnt were missing in BL/6J, but not BL/6N mice (Huang et al., 2006 ) ( Figure S1A ). In BL/6N mice, Nnt protein expression was highest in the heart, moderate in kidney and liver but absent from brain and skeletal muscle ( Figure S1B ). In heart, Nnt was expressed in myocytes and fibroblasts (Figures S1C and S1D). In contrast, Nnt expression was absent from any tissue in BL/ 6J mice (Figures S1B and S1C). Accordingly, Nnt enzymatic activity was detected in cardiac, but hardly in brain-and not in skeletal muscle mitochondria from BL/6N mice, while it was zero in any mitochondria in BL/6J mice ( Figure S1E ).
Since mitochondrial NADPH can be regenerated not only by the Nnt, but also by isocitrate dehydrogenase (IDH2) and malic enzyme (MEP) ( Figure 1A ), we ruled out a compensatory upregulation of these enzymes in BL/6J mitochondria (Figures S1F and S1G). Based on their NADPH-regenerating efficacies, IDH2 has the highest contribution to overall NADPH regenerating capacity in cardiac BL/6N mitochondria ($70%), followed by Nnt ($22%) and MEP (8%; Figure S1H ).
The Nnt mutation in BL/6J was originally discovered by this strain's impaired glucose tolerance (Toye et al., 2005) . As the underlying mechanism, glucose-induced oxidative stress in pancreatic beta cells was reported (Freeman et al., 2006) . Therefore, we compared Nnt activity to IDH2 and MEP activities in pancreatic islets of BL/6N and BL/6J mice. In the presence of ATP, which resembles the situation when glucose induces insulin release, IDH2 activity was largely suppressed ( Figure S1I (legend continued on next page) higher than IDH2 activity and therefore the dominating enzyme with NADPH-regenerating capacity under these conditions (Figures S1I and S1J) .
Nnt Contributes to NADPH Regeneration and ROS Elimination during a Physiological Workload Increase
To examine the functional consequences of Nnt deficiency for mitochondrial ROS formation, isolated cardiac myocytes were exposed to the b-adrenergic agonist isoproterenol and an increased stimulation rate ( Figure 1B ). This induced similar increases of sarcomere shortening, cytosolic and mitochondrial Ca 2+ without any differences between BL/6N and BL/6J myocytes ( Figures 1B, 1C , and S1K-S1L). Furthermore, DJ m remained stable during the protocol without differences between strains ( Figure 1D ). Electrical stimulation per se increased mitochondrial ROS formation ( Figures 1E and 1F ). While no differences in d O 2 À formation were observed between strains, H 2 O 2 (and presumably also other ROS due to the limited specificity of DCF to H 2 O 2 ) increased in BL/6J versus BL/6N myocytes during the workload transition ( Figures 1E and 1F ). These data are in agreement with the concept that during a physiological increase in workload triggered by b-adrenergic stimulation, the Nnt contributes to NADPH regeneration to fuel H 2 O 2 -detoxifying enzymes ( Figure 1A ).
Ameliorated Cardiac Remodeling in BL/6J versus BL/6N Mice after Pressure Overload Since mitochondrial ROS production plays an important role for cardiac remodeling in response to pressure overload (Dai et al., 2012) , we speculated that the lack of Nnt in BL/6J mice should aggravate the development of heart failure 6 weeks after transverse-aortic constriction (TAC). However, TAC led to similar increases in heart weight in both strains (Figure 2A ), and against our expectations, pulmonary congestion (indicating cardiac decompensation) was more frequent in BL/6N than in BL/6J mice ( Figure 2B ). Isolated working heart analyses revealed decreased left ventricular (LV) ejection fraction ( Figure 2C ) and elevated LV volume at 70 mmHg end-systolic pressure (integrating systolic dysfunction with LV enlargement; Figure S2A ) in BL/6N, but not BL/6J mice after TAC. Accordingly, mRNA expression of atrial natriuretic peptide (ANP), an index of LV filling pressures, was substantially increased after TAC in BL/ 6N and ameliorated in BL/6J mice ( Figure 2D ). Also, the increase in LV fibrosis was more pronounced in BL/6N than BL/6J mice ( Figures 2E and 2F ) despite similar increases in myocyte cross sectional area ( Figure 2G ). To understand the underlying mechanisms for these unexpected results, we analyzed nuclear staining of 8-hydroxy-2 0 -deoxyguanosine (8-OHdG) in LV myocardium as an indicator of intracellular ROS formation. In sham-operated animals, 8-OHdG staining was slightly elevated in BL/6J compared to BL/6N mice (Figures 2H and 2I) . In stark contrast, TAC substantially increased 8-OHdG staining in myocytes and non-myocytes from BL/6N, but not BL/6J hearts (Figures 2H, 2I, and S2B) . The levels of oxidative stress correlated with the degree of fibrosis, cardiac hypertrophy, ANP upregulation, and pulmonary congestion in BL/6N mice (p < 0.01, respectively), while these correlations were lost in BL/6J mice ( Figure 2J and data not shown).
To gain further insight into the mechanisms of remodeling, we performed gene array analyses. When applying a p value of <0.05 and a threshold of at least a 2-fold change, 148 genes were differentially regulated by TAC versus sham in BL/6N mice, while only 33 genes were differentially regulated in BL/6J mice ( Figure 2K ; Tables S1 and S2). Of these 33 genes, 26 were also regulated in BL/6N mice ( Figure 2K ), indicating similar, but clearly ameliorated TAC-induced genomic remodeling in BL/6J mice. Accordingly, pathway analyses revealed upregulation of cardiac hypertrophy and fibrosis pathways in BL/6N (p < 0.001, respectively; data not shown), but not BL/6J mice after TAC.
Of the fibrotic pathways, the most consistent change in BL/6N mice after TAC was of the gene encoding connective tissue growth factor (CTGF), which is inducible by H 2 O 2 (Park et al., 2001) . Real-time PCR confirmed strong upregulation of CTGF after TAC in BL/6N, which was blunted in BL/6J mice ( Figure 2L ). CTGF upregulation correlated closely with oxidative stress in hearts from BL/6N, but not BL/6J mice ( Figure 2M ). In contrast, other genes involved in fibrosis were not differentially regulated ( Figures S2C and S2D ).
An Unexpected Yin-Yang Role of the Nnt for the Regulation of Mitochondrial ROS
The analyses of 8-OHdG in LV myocardium (Figures 2H and 2I) indicate that in response to a pathological increase in cardiac afterload, oxidative stress is more pronounced in BL/6N than in BL/6J mice. Given that the Nnt is viewed as an antioxidative enzyme (Rydströ m, 2006) , supported by our results in cardiac myocytes during a physiological workload transition (Figures 1A and 1F) , this appeared paradoxical. Thus, we challenged our initial hypothesis and reasoned that under different metabolic conditions, the direction of the Nnt reaction may vary. A physiological workload transition (triggered by b-adrenergic activation) increases Ca 2+ and activates the Krebs cycle, compensating the ETC-induced oxidation of NADH (''parallel activation''; Figure 1A ) Maack et al., 2006) . In contrast, when increasing preload in isolated cardiac trabeculae, contractile force (and consequently ATP consumption) increase via the Frank Starling mechanism without a parallel increase in Ca 2+ (Backx and Ter Keurs, 1993) . Accordingly, increasing preload in cardiac trabeculae oxidizes NAD(P)H to NAD(P) + without a compensatory Ca 2+ -induced regeneration (Brandes and Bers, 1997) . We therefore reasoned that the in vitro conditions in un-stretched myocytes performing low levels of mechanical work, but with high Ca 2+ -stimulated Krebs cycle activity ( Figure 1 ) may be opposite to the in vivo conditions after TAC, with high mechanical workload without Ca 2+ -induced ''parallel activation'' of the Krebs cycle. To simulate such a pathological workload transition, we applied ADP to isolated cardiac mitochondria in the absence of Ca 2+ . In agreement with the prevailing paradigm of mitochondrial ROS production (Balaban et al., 2005) ). Indeed, this was opposite to the results in isolated myocytes exposed to b-adrenergic stimulation ( Figure 1F ), where ROS emission was higher in BL/6J than in BL/6N myocytes. In contrast, in mitochondria from brain and skeletal muscle of BL/6N mice, in which no Nnt activity was detected (Figure S1E), ADP lowered H 2 O 2 emission to a similar extent as d O 2 À without differences between strains ( Figures S3A-S3F ).
Reverse-Mode Nnt Oxidizes NADPH when Respiration Is Accelerated
Based on these opposing observations, we formulated the following hypothesis: accelerating respiration with ADP oxidizes NADH, and if NADH is not sufficiently regenerated by the Krebs cycle, NAD + provides a substrate for the reverse reaction of the Nnt, which is further facilitated by high NADPH, low NADH, and ADP-induced dissipation of Dm H ( Figure 3E ). This reversal of the Nnt oxidizes NADPH to regenerate NADH, which is consumed by the ETC. In fact, oxidation of the overall NAD(P)H/NAD(P) + redox pool by ADP was more pronounced in BL/6N than BL/6J mitochondria ( Figure 3D ). To interrogate this further, we measured mitochondrial NAD(P) H/NAD(P) + and FADH 2 /FAD redox states in isolated cardiac myocytes and exposed them to the uncoupler FCCP, the complex IV inhibitor cyanide and external H 2 O 2 ( Figure 3F ). Similar to ADP, FCCP accelerates respiration (by dissipating Dm H ) and thereby oxidizes NADH. While cyanide completely reduced the redox states of NAD(P)H/NAD(P) + and FADH 2 /FAD, H 2 O 2 completely oxidized both NADPH and NADH independent of the presence of Nnt.
In fact, FCCP led to an identical oxidation of the overall NAD(P) H/NAD(P) + redox pool as H 2 O 2 in BL/6N myocytes ( Figure 3F ). In contrast, in BL/6J myocytes, the oxidation of NAD(P)H/NAD(P) + by FCCP was less pronounced than by H 2 O 2 and less than by FCCP in BL/6N myocytes ( Figures 3F and 3G) . The redox state Figure 3H ). Since the Nnt is coupled to Dm H , a reversal of the Nnt should also reverse the direction of proton translocation across the inner mitochondrial membrane, thereby possibly contributing to DJ m ( Figure 3E ). In fact, when accelerating respiration in isolated myocytes with FCCP, DJ m dissipated slightly faster in BL/6J than in BL/6N myocytes ( Figures S3G and S3H ), indicating that reverse-mode Nnt might delay dissipation of DJ m by consuming NADPH. Similar results were obtained when Nnt was inhibited acutely with a chemical inhibitor (NBD-chloride) in BL/6N myocytes ( Figures S3I and S3J ). Despite this slight delay, DJ m was dissipated by similar extents in myocytes from BL/6N and BL/6J mice. In agreement with this, steady-state DJ m was unchanged in isolated and energized BL/6N and BL/6J mitochondria after titration of the uncoupler DNP, in the absence or presence of nigericin (that dissipates DpH, but not DJ m ; Figures S3K and S3L ), suggesting that the overall contribution of reverse-mode Nnt to DJ m is rather small.
In isolated cardiac myocytes, for any given DJ m during FCCP-induced dissipation, the redox state of NAD(P)H/ NAD(P) + remained more reduced in BL/6J than in BL/6N mitochondria ( Figure 3I ), further supporting that Nnt-deficiency may maintain NADPH during accelerated respiration. To test this further, we employed fluorescence lifetime imaging (FLIM), where the longer time constant of NAD(P)H fluorescence decay (t bound ) reflects the ratio of bound NADPH to NADH (Blacker et al., 2014) . In agreement with previous data on HEK cells, FCCP did not change t bound in BL/6N myocytes ( Figure 3J) , since NADH and NADPH are oxidized by FCCP to similar extents, presumably through equilibration of both pools via the Nnt (Blacker et al., 2014) . In contrast, FCCP caused a small but significant increase in t bound in BL/6J myocytes, indicating more pronounced oxidation of NADH than NADPH ( Figure 3J ). Vice versa, blocking the ETC with cyanide reduces the redox state of NADH, and since the total pool of NADH is larger than the NADPH pool, t bound shifts further toward the value predicted for purely NADH ($1.5 ns; Figure 3J ). This was even more pronounced in BL/6J myocytes, where a lack of forwardmode Nnt may hinder complete NADPH reduction. Therefore, when dividing the estimated NADPH/NADH ratios after FCCP by the ratios after cyanide, respectively, the greater values in BL/6J myocytes indicate that the NADPH pool is more ''uncoupled'' from the NADH pool (compared to BL/6N; Figure 3K ), consistent with a lack of Nnt-mediated equilibration of NADH and NADPH pools in either direction and supporting the idea that NADPH is relatively conserved after oxidation of NADH by FCCP.
Furthermore, we performed computational modeling using a two-compartment model that integrates mitochondrial energetics with redox regulation (Kembro et al., 2013) . Starting from low extra-mitochondrial [ADP] of 5 mM, transient increases of [ADP] to 20, 30, and 40 mM increased mitochondrial [ADP] (Figure 4A) , dissipated DJ m and oxidized NADH ( Figures 4B and  4C ). While at low [ADP], the Nnt operated in the forward mode, it reversed direction during NADH oxidation, inducing NADPH oxidation ( Figures 4D and 4E ). Reducing Nnt activity 10,000fold prevented NADPH oxidation ( Figure 4E ) despite similar NADH oxidation and DJ m dissipation ( Figures 4B and 4C) . Of note, the Nnt reverses already early after initiation of NADH oxidation, however, the impact on NADPH becomes particularly relevant at strongly oxidized NADH levels ( Figure 4F ). Together, these data imply that acceleration of NADH-coupled respiration during metabolic perturbations facilitates Nnt-mediated NADPH oxidation, while Nnt-deficiency maintains the NADPH pool under these conditions.
Reverse-Mode Nnt Oxidizes Glutathione and Peroxiredoxin in Response to Increased Afterload
To test the relevance of reverse-mode Nnt on the whole organ level, we performed experiments on isolated working hearts exposed to a physiological pre-and afterload of 10 and 80 mmHg, respectively. Under these conditions, the redox states of glutathione and peroxiredoxin, which are regenerated by NADPH ( Figure 1A) , were slightly more oxidized in BL/6J versus BL/6N hearts ( Figures 5C, 5D, 5F, and 5G) . In contrast, when afterload was increased from 80 to 120 mmHg for 15 min (Figure 5A) , it led to stronger oxidation of glutathione and peroxiredoxin in BL/6N versus BL/6J hearts ( Figures  5B-5H ). Reduced peroxiredoxin exists in a monomeric form, while oxidation causes dimerization (Kumar et al., Figure 5 . Increasing Afterload Induces Nnt-Mediated Oxidation of Glutathione and Peroxiredoxin Isolated working hearts from BL/6N and BL/6J mice were held at a preload of 10 mmHg and afterload of 80 mmHg (400 bpm). Afterload was increased to 120 mmHg (AL) or maintained at 80 mmHg (Con). After 15 min, hearts were snap-frozen for biochemical analyses. 2009). Upon afterload elevation, the degree of dimerization of the mitochondrial isoform peroxiredoxin III was increased in BL/6N, but not BL/6J hearts ( Figures 5I and 5J) , further pinpointing mitochondria as the main source for oxidative stress under these conditions. Accordingly, afterload-induced increases in lipid peroxidation were more pronounced in BL/ 6N than in BL/6J hearts ( Figure 5K ). Taken together, these data are in good agreement with the in vivo data ( Figures  2H and 2I) , where ROS levels were slightly lower in shamoperated-, but much higher in TAC-operated BL/6N versus BL/6J mice. 
Targeting Mitochondrial ROS Production Reduces Necrosis and Early Mortality in Response to
Increased Afterload In Vivo To analyze whether mitochondrial ROS production is the key difference between BL/6N and BL/6J mice in response to increased afterload, we combined TAC or sham-operation with the implantation of osmotic minipumps releasing either vehicle or SS-31, a tetrapeptide that reduces mitochondrial ROS production (Szeto, 2014) . Vehicle-treated BL/6N mice suffered $50% mortality in 6 weeks, while most BL/6J mice survived this intervention ( Figures 6A-6C ). SS-31 reduced TAC-induced mortality in BL/6N mice to levels of vehicle-treated BL/6J mice ( Figures 6A and 6B) . Although TAC-induced increases in lipid peroxidation were more pronounced in BL/6N than in BL/6J mice and sensitive to SS-31 ( Figures 6D-6F ), no differences in cardiac hypertrophy were observed between strains and by treatment ( Figures S4A and  S4B) . Despite a mortality-induced selection bias, SS-31 ameliorated ANP upregulation in BL/6N mice, while the TAC-induced increase in CTGF was insensitive to SS-31 ( Figures S4C and S4D) .
Mitochondrial ROS can trigger the opening of the permeability transition pore (PTP), dissipate DJ m , and induce apoptotic and/ or necrotic cell death (Halestrap, 2005) . After only 3 days of TAC, necrotic cell death increased in hearts of TAC-operated BL/6N, but not BL/6J mice ( Figure 6G ). For any given increase in ANP expression as an index of hemodynamic load, TAC-induced necrosis was 4-to 5-fold more pronounced in BL/6N mice than in BL/6J mice (not shown), and this was prevented by SS-31 ( Figure 6H ). Similar, albeit less pronounced results were obtained for the activities of caspase-3 and caspase-7 as inducers of apoptosis ( Figure 6I ). The PTP inhibitor cyclosporin A reduced necrosis in TAC-treated BL/6N hearts (to 1.3% ± 0.4%). However, due to a slight anti-necrotic effect of the oil-based vehicle, this effect was not significantly different from its control (not shown). Further experiments on isolated mitochondria revealed that ameliorated necrosis in BL/6J mice was not related to modified properties of the PTP per se, since Ca 2+ and ROS induced similar PTP opening in both strains ( Figures S4E and S4F) .
To test whether the levels of oxidative stress that occur after TAC in BL/6N mice are sufficient to induce cardiomyocyte death, we exposed isolated perfused BL/6N hearts to increasing concentrations of exogenous H 2 O 2 and observed that 100 mM H 2 O 2 oxidized the glutathione pool by 40% ( Figure 6J ), a similar extent as after increasing afterload from 80 to 120 mmHg in working hearts (41%; Figure 5D ). Applying 100 mM H 2 O 2 to isolated BL/6N cardiomyocytes dissipated DJ m by 50% after $12 min, which was delayed by cyclosporin A and even more by SS-31 ( Figure 6K ).
Re-expression of the Nnt in BL/6J Mice Re-establishes Oxidative Stress in Response to Pressure Overload
To rule out that other genomic differences between BL/6N and BL/6J mice (Simon et al., 2013) account for differential ROS production, we obtained BL/6J mice that harbor one allele with the intact wild-type (wt) and one with the truncated (t) Nnt gene (BL/6J-Nnt wt/t ) (Kim et al., 2010) . From this strain, we generated BL/6J-Nnt t/t , BL/6J-Nnt wt/t , and BL/6J-Nnt wt/wt mice. Reexpression of intact Nnt in BL/6J mice increased Nnt activity to levels observed in BL/6N mice ( Figure 7A ). Three days after TAC, mRNA expression of brain natriuretic peptide (BNP), an index of LV filling pressures, increased ( Figure 7B ), together with more pronounced oxidation of peroxiredoxin and oxidative stress (indexed by 8-OHdG) in wild-type Nnt-expressing mice in vivo ( Figures 7C-7F ). For any given TAC-induced increase of cardiomyocyte cross sectional area, the increase in ROS in vivo was higher in BL/6J-Nnt wt/wt mice compared to BL/6J-Nnt t/t or BL/6J-Nnt wt/t (Figure 7G ). Taken together, these data indicate that the lower TAC-induced mitochondrial ROS emission in BL/ 6J mice was primarily related to the absence of a functional Nnt.
DISCUSSION
Our study revealed that besides its canonical antioxidant function, the mitochondrial transhydrogenase (Nnt) can switch to a pro-oxidative reverse mode that triggers NADPH oxidation during a pathological increase of workload in cardiac mitochondria ( Figure 7H ). This pro-oxidative shift provokes mitochondrial ROS emission and induces necrotic cell death, fibrosis, cardiac dysfunction, and death. To our knowledge, this is the first bona fide mechanism that explains how a pathological increase in cardiac workload per se increases mitochondrial ROS emission independent of neuroendocrine activation. The missense of a functional Nnt in BL/6J mice substantially ameliorates oxidative stress, maladaptive remodeling, and LV dysfunction and reduces death in response to pressure overload. This finding has broad implications since it sheds new light on many previous studies using this strain to analyze the consequences of other, non-mitochondrial sources of ROS for cardiac remodeling and the development of heart failure. Furthermore, differential tissue-specific expression of the Nnt adds another level of complexity to the regulation of mitochondrial ROS emission in different tissues under variable metabolic conditions. Finally, targeting mitochondrial ROS production with the tetrapeptide SS-31, which is already in clinical testing, may be an efficient therapy of heart failure.
Pathophysiological Role of Mitochondrial ROS in Heart Failure
Oxidative stress in the plasma and myocardium of patients with heart failure correlates with LV dysfunction (Belch et al., 1991; Maack et al., 2003) . Besides mitochondria, other relevant ROS sources in cardiac myocytes are NADPH oxidases, uncoupled nitric oxide synthases, monoamine oxidase A, and xanthine oxidase. The relative contribution of these sources to overall myocardial ROS production during the development of heart failure, however, is unknown. A common approach to estimate the role of a particular ROS source is to apply TAC in mice with genetic modifications of proteins involved in ROS production. In fact, most of these studies were performed on BL/6J mice (Table  S1 ). Our data indicate that in BL/6J mice, contribution of mitochondria to cellular ROS production, and maladaptive remodeling in response to TAC is heavily underestimated or even absent ( Figure 2I ), implying that studies using BL/6J may overestimate the contribution of non-mitochondrial ROS sources. In contrast, overexpressing a mitochondria-targeted catalase in BL/6N mice protected hearts from maladaptive remodeling in response to TAC (Dai et al., 2012) . Since in our study, inhibiting mitochondrial ROS emission with the tetrapeptide SS-31 rescued TACinduced mortality in BL/6N, but not BL/6J mice, these data imply that mitochondria are the dominant source of ROS during pathological elevations of afterload. In humans, chronic elevations of afterload are a central feature of various cardiovascular diseases, such as arterial hypertension, aortic stenosis or vascular stiffness imposed by atherosclerosis and/or aging. All these ageassociated conditions are known risk factors for the development of heart failure. A previous study observed downregulation of Nnt activity in human failing hearts, which was associated with oxidation of glutathione (Sheeran et al., 2010) . While these authors suggested that downregulation of Nnt activity may contribute to oxidative stress, the data of our study rather imply that Nnt downregulation in human heart failure may be protective by reducing reverse-mode Nnt-mediated mitochondrial ROS emission.
Already 3 days after TAC, the rates of apoptosis and necrosis were strikingly different between strains. In human heart failure, the levels of apoptosis are increased (Olivetti et al., 1997) , and even low rates of cardiomyocyte death are sufficient to cause a lethal dilated cardiomyopathy (Wencker et al., 2003) . In human heart failure, elevated levels of high-sensitive troponin T, a marker for cardiomyocyte necrosis, predict an adverse clinical outcome (Masson et al., 2012) . SS-31 accumulates in mitochondria and protects cardiolipin and other mitochondrial proteins from oxidative damage, which may interrupt a feed-forward pathway of mitochondrial dysfunction and ROS production (Dai et al., 2013; Szeto, 2014) . In our study, SS-31 prevented necrosis and (partly) apoptosis, while CTGF upregulation appeared unaffected. These data are in agreement with, and at the same time extend, previous data in which SS-31 prevented 84% of TACinduced proteomic remodeling in BL/6N mitochondria (Dai et al., 2013) . Ongoing clinical studies will have to verify whether SS-31 is of clinical use in patients with heart failure (Szeto, 2014) .
Reverse-Mode Nnt Modifies Current Paradigm of Mitochondrial ROS Production
The current paradigm of mitochondrial ROS production implies that dissipating DJ m by accelerating respiration with ADP (or activation of uncoupling proteins) generally reduces mitochondrial oxidative stress (Balaban et al., 2005) . In contrast, we observed that H 2 O 2 emission was lowered by ADP only in the absence of an Nnt in BL/6J, but not BL/6N cardiac mitochondria. This is in seeming contrast to other studies on which the current paradigm is based on. For instance, in isolated rat cardiac mitochondria, H 2 O 2 emission decreased when respiration was accelerated by ADP or chemical uncoupling (Korshunov et al., 1997) . In that study, however, the mitochondrial H 2 O 2 -scavenging capacity was eliminated by pretreatment of mitochondria with H 2 O 2 and aminotriazole, so that H 2 O 2 emission was governed primarily by d O 2 À production at the ETC and no longer counterbalanced by NADPH-dependent H 2 O 2 elimination. Furthermore, H 2 O 2 emission from brain mitochondria was maximal at reduced redox states of NAD(P)H, while chemical or ADP-induced uncoupling of DJ m lowered it (Starkov and Fiskum, 2003) . However, brain mitochondria do not express the Nnt (Figure S1B ), and we could reconcile their findings in brain mitochondria from BL/6N mice, where ADP reduced H 2 O 2 emission to a similar extent as in brain mitochondria from BL/6J mice ( Figure S3 ). Taken together, differential Nnt expression accounts for tissue-specific differences in the regulation of mitochondrial ROS emission that may also explain why in contrast to results on brain mitochondria (Starkov and Fiskum, 2003) , we previously observed an inverse (and not positive) correlation between the redox state of NAD(P)H and H 2 O 2 emission in cardiac myocytes (Kohlhaas et al., 2010) .
Organ-Specific Relevance of Nnt for Antioxidative Capacity
Interestingly, under physiological (unstressed) conditions, impaired glucose tolerance due to ROS-dependent impairment of insulin release is so far the only known phenotype provoked by the mutation of the Nnt in BL/6J mice (Simon et al., 2013; Toye et al., 2005) . One explanation may be that the high efficacy of IDH2 to regenerate NADPH (Figures S1F and S1H) can compensate for the loss of the Nnt at least in cardiac mitochondria. In contrast, in pancreatic islets from BL/6N and BL/ 6J mice we observed that in the presence of physiological levels of ATP, IDH2 activity was largely suppressed (Figures S1I and S1J). Thus, when high glucose triggers an elevation of ATP and insulin secretion in the pancreas, the lack of Nnt in BL/6J may deteriorate the NADPH regenerative capacity and induce oxidative stress to a higher extent in this organ compared to other organs in which IDH2 can compensate for the loss of Nnt.
Limitations
Since we did not apply knockout technology, we cannot fully rule out that apart from Nnt expression, also other genetic differences between BL/6N and BL/6J mice may contribute to the differences in oxidative stress and/or maladaptive remodeling between the strains. However, since (1) re-expression of one or two wild-type Nnt alleles in BL/6J mice re-increased oxidative stress after TAC (Figure 7) , and (2) no differences in mitochondrial d O 2 À production or H 2 O 2 emission were observed between the strains in the absence of ADP (State 4; Figures 3B  and 3C ), other mechanisms than differential Nnt expression appear unlikely to account for the differences in ROS emission when ADP accelerates respiration at higher workloads. Another limitation is that NADPH could not be measured directly and separated from fluorescent NADH signals, which is technically challenging. Nevertheless, the information gathered from NADPH/NADH ratios determined by FLIM ( Figures 3J and 3K ) during mitochondrial perturbations and data from computational modeling (Figure 4 ) support the concept that oxidation of NADH at the ETC can provoke the reverse mode of the Nnt to oxidize NADPH.
Conclusions
We identified a mechanism that couples a pathological increase in metabolic demand to increased mitochondrial ROS emission in the heart ( Figure 7H ). The discovery of the previously unappreciated reverse-mode of the Nnt assigns this enzyme a dual role serving either pro-or antioxidative processes depending on the metabolic state of a cell. Considering the overarching importance of ROS production in aging and aging-related diseases, these data provide important new insights into the mechanisms of redox regulation under physiological and pathological conditions in various tissues. Targeting mitochondrial ROS emission is therefore a promising approach to ameliorate aging-related diseases and in particular, heart failure.
EXPERIMENTAL PROCEDURES
Animal Experiments
Animal procedures were approved by the local animal ethics committee and conducted in accordance with institutional guidelines. C57BL/6 mice were obtained from Charles River (BL/6N, C57BL/6NCrl, strain code 027; and BL/J, C57BL/6J, JAX Mice Stock Number 000664). N5 BL/6J-Nnt wt/t mice (Kim et al., 2010) were obtained from Jackson Laboratories and further bred at our institution, generating BL/6J-Nnt t/t , BL/6J-Nnt wt/t and BL/6J-Nnt wt/wt mice.
Transaortic Constriction
Transaortic constriction (TAC) was performed as described in more detail in the Supplemental Experimental Procedures. Mice (10-to 12-week-old) underwent TAC or sham surgery and were followed for 6 weeks or 3 days. A literature research was performed for other studies that performed TAC in normal or genetically modified BL/6N and BL/6J mice (Table S1 ). For drug treatment, osmotic minipumps (Alzet #2006) were implanted $20 min after TAC and loaded with SS-31 (3 mg/kg 3 d) or vehicle (0.9% NaCl) for 6 weeks. In 3-day experiments, SS-31 was injected intraperitoneally (i.p.) (0.5 mg/ml, 0.9% NaCl) and compared to 0.9% NaCl.
Echocardiography
Echocardiography was performed as described in more detail in the Supplemental Experimental Procedures section on anaesthetized mice using a Visualsonics Vevo 770 High-Resolution in vivo Micro-Imaging System (Visualsonics).
Isolated Working Hearts Experiments
For hemodynamics, hearts were mounted in a working heart apparatus and analyzed with a pressure-volume catheter as described in the Supplemental Experimental Procedures. Hearts equilibrated at 10 mmHg preload and 80 mmHg afterload at 400 bpm external pacing. Then afterload was increased to 120 mmHg or maintained at 80 mmHg for 15 min.
Isolated Cardiac Myocytes
Cardiac myocytes were isolated by enzymatic digestion and experiments performed as described in the Supplemental Experimental Procedures and Table  S2 . Briefly, adult ventricular myocytes were electrically stimulated at 0.5 Hz and then exposed to isoproterenol (30 nM) and an increase of stimulation rate to 5 Hz for 3 min. Sarcomere shortening was detected together with either (1) the redox state of NAD(P)H/NAD(P) + and FADH 2 /FAD by autofluorescence, (Maack et al., 2006) . Quiescent myocytes (Figures 3F and 3G) were exposed to FCCP (5 mM), cyanide (4 mM), and H 2 O 2 (10 mM) and NAD(P)H/NAD(P) + and FADH 2 /FAD were determined in the same cells, respectively. DJ m (TMRM) was determined together with NAD(P)H in myocytes exposed to FCCP (5 mM) and oligomycin (1.26 mM; Figures S3G-S3J ).
NAD(P)H Fluorescence Lifetime Imaging Experiments
Cardiac myocytes were allowed to adhere to glass coverslips for >2 hr before imaging. At the microscope, coverslips were maintained at 37 C in a home built chamber and bathed in DMEM (GIBCO) containing (in mM) glucose 25, pyruvate 1, glutamine 2, and HEPES 10. NAD(P)H fluorescence lifetime imaging (FLIM) was described previously (Blacker et al., 2014) and in further detail in the Supplemental Experimental Procedures. Five minutes prior to application of pharmacological treatments, 10 mM blebbistatin was applied to prevent contraction during FLIM image acquisition. Control experiments showed that blebbistatin did not alter the FLIM parameters a bound (p = 0.2, n = 3, 14 images), t free (p = 0.2) or t bound (p = 0.1).
Isolated Mitochondria
Mitochondria were isolated from heart, brain and skeletal muscle by standard techniques as described in the Supplemental Experimental Procedures. Mitochondria were supplied with pyruvate/malate as substrates (5/5 mM). Respiration (Clark electrode), d O 2 À formation (electron paramagnetic resonance, EPR), H 2 O 2 emission (Amplex Ultra-Red), or NAD(P)H autofluorescence were determined in the absence or presence of ADP (1 mM), respectively. DJ m was determined using triphenylmethylphosphonium (TPMP + ).
Real-Time PCR, Gene Array, and Western Blot Analysis
Real-time PCR, gene array, and western blot analyses were performed by standard techniques as described in more details in the Supplemental Experimental Procedures. The secondary antibody against Nnt was provided by Ting-Ting Huang (University of California, San Francisco). Gene array experiments were performed using the Affymetrix GeneChip Mouse Gene 1.0 ST Array. The gene array accession number of the data in Tables S3 and S4 is ''E-MTAB-2732'' at ArrayExpress.
Histological Analyses
Histological analyses were performed by standard techniques with details outlined in the Supplemental Experimental Procedures. H&E staining was used for cardiomyocyte morphometry, picrosirius red staining for fibrosis, and 8-hydroxy-2 0 -deoxyguanosine (8-OHdG) for intracellular ROS detection. Evans blue staining (indexing necrosis) was detected after i.p. application of 100 ml of Evans blue solution (16.7 mg/ml) 1 day before sacrifice.
Enzyme Activities
Details on enzymatic activity measurements are provided in the Supplemental Experimental Procedures. Activities of Nnt, IDH2, and MEP were analyzed by NADPH-or APAD-coupled spectrophotometric assays in homogenates of isolated cardiac mitochondria.
GSH/GSSG Measurements
Determination of GSH and GSSG was performed as described previously (Rahman et al., 2006) and as outlined in more detail in the Supplemental Experimental Procedures. For GSSG measurements, 3 mM of 1-methyl-2-vinylpyridine was added for derivatization of reduced GSH before homogenization. Reduced GSH was calculated as the difference between total glutathione and GSSG.
Malondialdehyde Concentrations
Lipid peroxidation was determined using the ALDetect Lipid Peroxidation Assay Kit (ENZO Life Science) to detect the concentrations of malondialdehydes (MDA) according to the manufacturer's protocol. As a variation from that protocol, the sample volume was reduced from 200 ml to 150 ml.
Caspase-3/7 Activity The Caspase-Glo 3/7 Assay (Promega) was used to measure caspase-3 and caspase-7 activities. Heart lysates (50 mg) were mixed with reaction solution at equal volumes in a 96-well plate. Luminescence was detected after 20 min (at 37 C) and activities normalized to a standard of caspase-3.
Computational Modeling
Computational modeling of NADH, NADPH, DJ m , and Nnt activity was performed with the integrated model of mitochondrial energetics, redox, and ROS metabolic networks (Kembro et al., 2013) . The model parameters were as in Kembro et al. (2013) , except for cytoplasmic ADP that was driven by an exogenous function. The baseline level of cytoplasmic ADP was 5 mM, with pulses of 20, 30, and 40 mM added for 200 s as shown by the ADP m transients in Figure 4A . To simulate the absence of Nnt activity, its forward and reverse rate constants were reduced 10,000-fold.
Statistical Analyses
Values are displayed as mean ± SEM. One-way ANOVA followed by Tukey's multiple comparisons test, paired, and unpaired t tests, Fisher's exact test, and Kaplan-Meier survival analyses were performed using GraphPad Prism version 6.00 for Windows (GraphPad, http://www.graphpad.com).
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